CasaPharma
The computed 12-month bankruptcy probability of CasaPharma is 0.2% (very low). The 2024 annual accounts show negative equity (€-559) and a net result of €7k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 8% of 1384 sector peers (fiscal year 2024). The company has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-559 |
| Net result | €7k |
| Better than sector | 8% |
| Active | 14 yrs |
Mixed profile: strong on stability, weaker on profitability.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -2.2% | 43.4% | |
| Net result | €7k | €42k | |
| Equity | €-559 | €163k | |
| Gross operating margin | €8k | €72k | |
| Total assets | €26k | €607k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | - |
| Net profit | €7k |
| Cash flow | - |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €26k |
| Equity | €-559 |
| Debt | €26k |
| of which ≤ 1y | €26k |
| of which > 1y | - |
| Working capital | €-559 |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 0.98 |
| Quick ratio | 0.98 |
| Working capital ratio | -2.2% |
| Solvency | -2.2% |
| Debt / equity | -47.35 |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | 28.6% |
| ROE | -1325.6% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €26k |
| Current assets | 29/58 | €26k |
| Amounts receivable within one year | 40/41 | €11k |
| Cash & bank | 54/58 | €15k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €26k |
| Equity | 10/15 | €-559 |
| Contributions / capital | 10/11 | €19k |
| Accumulated profits (losses) | 14 | €-19k |
| Amounts payable | 17/49 | €26k |
| Amounts payable within one year | 42/48 | €26k |
| Trade debts payable within one year | 44 | €8k |
| Income statement | ||
| Gross operating margin | 9900 | €8k |
| Operating result | 9901 | €8k |
| Financial charges | 65 | €94 |
| Result before taxes | 9903 | €7k |
| Net result for the period | 9904 | €7k |
| Result to be appropriated | 9905 | €7k |
-
Current20-10-2023 → present
Former directors (2)
-
Former- → 20-10-2023
-
Former- → 20-10-2023
| NACE primary | Head offices & management consulting(70200) |
| Legal form | Private limited company(610) |
| Incorporation | 11-07-2012 |
| Status | Active |
| Postal code | 9910 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44067B0005/00X000 | Flanders | 224 m² | 1 · 111 m² | 5.0 m · 1 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
25-02-2026 All shares are now held by a single shareholder
Technical details
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2026-02-25",
"filing_date": null,
"act_kind_objet": "Vereniging van alle aandelen in \u00E9\u00E9n hand"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": "2026-02-17",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": "2026-02-13"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0847.310.935",
"name_full": "CasaPharma",
"legal_form": "B.V.",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [],
"share_classes_after": []
}05-01-2024 1 director appointed, 1 resigning
- Rottey Erika, Bestuurder
- ROEGIERS Paul Maurice Maria, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "ROEGIERS Paul Maurice Maria",
"address": null,
"birth_date": null
},
"effective_date": "2023-10-20",
"evidence_quote": "De algemene vergadering ... bevestigt bij deze de beslissingen genomen bij de algemene vergadering dedato twintig oktober laatst zijnde dat de heer ROEGIERS Paul Maurice Maria, wonende te 9960 Assenede, Vrijestraat 28, ontslagen is van zijn opdracht als bestuurder met ingang van twintig oktober laat"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Rottey Erika",
"address": null,
"birth_date": null
},
"effective_date": "2023-10-20",
"evidence_quote": "en dat mevrouw Erika Rottey, voornoemd, als enige bestuurder in zijn plaats werd benoemd met ingang van twintig oktober laatst"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0847.310.935",
"name_full": "CASAPHARMA",
"legal_form": "BVBA"
}
}14-12-2023 1 director appointed, 1 resigning
- Erika Rottey, Bestuurder
- Paul Roegiers, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Paul Roegiers",
"address": null,
"birth_date": null
},
"effective_date": "2023-10-20",
"evidence_quote": "De bijzondere algemene vergadering beslist met ingang van 20/10/2023 een einde te stellen aan het mandaat van de bestuurder van Paul Roegiers.",
"discharge_granted": true
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Erika Rottey",
"address": null,
"birth_date": null
},
"effective_date": "2023-10-20",
"evidence_quote": "De vergadering beslist als nieuwe bestuurder te benoemen: Erika Rottey, haar mandaat gaat in op 20/10/2023 en is van onbepaalde duur."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0847.310.935",
"name_full": "CASAPHARMA",
"legal_form": "BVBA"
}
}13-02-2017 Registered office moved from Evere to Gent
- Jules Bordetlaan 160, 1140 Evere → Coupure Links 505, 9000 Gent
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Gent",
"region": null,
"street": "Coupure Links",
"country": "BE",
"postcode": "9000",
"box_number": null,
"street_number": "505"
},
"old_address": {
"city": "Evere",
"region": null,
"street": "Jules Bordetlaan",
"country": "BE",
"postcode": "1140",
"box_number": null,
"street_number": "160"
},
"effective_date": "2016-09-07",
"evidence_quote": "De zaakvoerder beslist om vanaf heden de maatschappelijke zetel te verplaatsen van Jules Bordetlaan 160, 1140 Evere naar Coupure Links 505, 9000 Gent."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0847.310.935",
"name_full": "CASAPHARMA",
"legal_form": "BVBA"
}
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | CasaPharma |